文献速递神经儿科影像MR

无钆对比剂脑肿瘤成像:可行还是幻想?

Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy?
PubMed 文献 · Radiology · 2024-01-01

本文综述儿童与成人原发性脑肿瘤(胶质瘤和脑膜瘤)减少或避免钆对比剂(GBCA)的成像策略。早期术后MRI和胶质瘤固定间隔成像的生存获益不确定;半剂量GBCA用于胶质瘤、仅T2加权成像用于脑膜瘤是可减少GBCA使用的选项。多数指南推荐诊断和治疗各阶段使用GBCA,但非增强序列如动脉自旋标记已显示很大潜力,人工智能生成合成增强图像也显示出替代GBCA依赖方法的希望。

要点

  • 早期术后MRI和胶质瘤固定间隔成像的生存获益不确定,属可减少GBCA暴露的场景。
  • 胶质瘤可考虑半剂量GBCA,脑膜瘤可仅用T2加权成像以减少GBCA使用。
  • 动脉自旋标记等非增强序列及人工智能合成增强图像显示出替代GBCA依赖方法的潜力。

核心结论

  • 基于当前文献综述,儿童和成人原发性脑肿瘤存在减少GBCA暴露的成像策略,但需关注所综述文献的质量和实际适用性。

研究设计与样本

  • 综述,聚焦儿童和成人胶质瘤与脑膜瘤,基于当前文献回顾减少GBCA暴露的成像策略,特别关注所综述文献的质量和实际适用性。

诊断标准与关键数值

  • 胶质瘤可考虑半剂量GBCA以减少GBCA使用。
  • 脑膜瘤可仅用T2加权成像以减少GBCA使用。

临床应用与阅片要点

  • 早期术后MRI和胶质瘤固定间隔成像属GBCA暴露但生存获益不确定的场景。
  • 多数成像指南推荐诊断和治疗各阶段使用GBCA。
  • 动脉自旋标记等非增强序列已显示出很大潜力。
  • 人工智能方法从减剂量或无GBCA扫描生成合成增强图像已显示出替代GBCA依赖方法的希望。

局限性

  • 原文特别关注所综述文献的质量和实际适用性,提示文献质量与真实场景适用性存在不确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Gadolinium-based contrast agents (GBCAs) form the cornerstone of current primary brain tumor MRI protocols at all stages of the patient journey. Though an imperfect measure of tumor grade, GBCAs are repeatedly used for diagnosis and monitoring. In practice, however, radiologists will encounter situations where GBCA injection is not needed or of doubtful benefit. Reducing GBCA administration could improve the patient burden of (repeated) imaging (especially in vulnerable patient groups, such as children), minimize risks of putative side effects, and benefit costs, logistics, and the environmental footprint. On the basis of the current literature, imaging strategies to reduce GBCA exposure for pediatric and adult patients with primary brain tumors will be reviewed. Early postoperative MRI and fixed-interval imaging of gliomas are examples of GBCA exposure with uncertain survival benefits. Half-dose GBCAs for gliomas and T2-weighted imaging alone for meningiomas are among options to reduce GBCA use. While most imaging guidelines recommend using GBCAs at all stages of diagnosis and treatment, non-contrast-enhanced sequences, such as the arterial spin labeling, have shown a great potential. Artificial intelligence methods to generate synthetic postcontrast images from decreased-dose or non-GBCA scans have shown promise to replace GBCA-dependent approaches. This review is focused on pediatric and adult gliomas and meningiomas. Special attention is paid to the quality and real-life applicability of the reviewed literature.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Wamelink IJHG, Azizova A, Booth TC, et al. Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy? Radiology. 2024. PMID: 38319162. doi:10.1148/radiol.230793

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。